...
首页> 外文期刊>Transplantation: Official Journal of the Transplantation Society >Antithymocyte globulin affects the occurrence of acute and chronic graft-versus-host disease after a reduced-intensity conditioning regimen by modulating mixed chimerism induction and immune reconstitution.
【24h】

Antithymocyte globulin affects the occurrence of acute and chronic graft-versus-host disease after a reduced-intensity conditioning regimen by modulating mixed chimerism induction and immune reconstitution.

机译:在降低强度的调节方案后,抗胸腺细胞球蛋白通过调节混合嵌合体诱导和免疫重建影响急性和慢性移植物抗宿主病的发生。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: There have been no detailed analyses of the induction of donor cell-type chimerism, the onset and incidence of acute and chronic graft-versus-host disease (GVHD), and the immune recovery kinetics after reduced-intensity stem cell transplantation (RIST). METHODS: To address these, with particular emphasis on the impact of the use of antithymocyte globulin (ATG) in RIST, we compared 39 consecutively registered patients who underwent RIST from an HLA-matched related donor and 33 patients who underwent conventional marrow-ablative transplantation. RESULTS: The incidences of grades II to IV acute and chronic GVHD tended to be less in RIST with ATG than in either RIST without ATG or conventional marrow-ablative transplantation. In a multivariate analysis, the predictive factors for acute and chronic GVHD included, respectively, ATG and grades II to IV acute GVHD. In a chimerism analysis, the achievement of complete donor chimera in T-cell lineage was delayed in RIST without ATG compared with RISTwith ATG (P=0.038), which might explain the observed delayed onset of acute GVHD in RIST with ATG compared with the other two regimens. The ratio of type 1 and 2 dendritic cells did not affect the development of GVHD, whereas the number of naive CD4+ T cells did. No difference was observed in the incidence of clinically definitive infection, including cytomegalovirus, among the three cohorts, regardless of the use of ATG. CONCLUSIONS: We suggest that the conditioning regimen and immunosuppressive strategy after RIST should be carefully balanced against the risk of GVHD and of relapse of the basic disorder caused by the lack of a graft-versus-leukemia benefit.
机译:背景:目前尚无关于诱导供体细胞型嵌合体,急性和慢性移植物抗宿主病(GVHD)的发生和发病率以及强度降低的干细胞移植(RIST)后免疫恢复动力学的详细分析。 )。方法:为了解决这些问题,特别强调在RIST中使用抗胸腺细胞球蛋白(ATG)的影响,我们比较了39例从HLA匹配相关供体接受RIST的连续注册患者和33例进行了常规骨髓切除术的患者。结果:有ATG的RIST患者中II至IV级急性和慢性GVHD的发生率往往低于无ATG的RIST患者或常规骨髓切除术移植患者。在多变量分析中,急性和慢性GVHD的预测因素分别包括ATG和II至IV级急性GVHD。在嵌合分析中,与无ATG的RIST相比,无ATG的RIST中T细胞谱系完全供体嵌合的完成被延迟(P = 0.038),这可能解释了与ATG相比,在RIST中,与ATG相比,急性GVHD的延迟发作两种方案。 1型和2型树突状细胞的比例不影响GVHD的发育,而幼稚CD4 + T细胞的数目却影响。不论是否使用ATG,在这三个队列中,临床确定性感染(包括巨细胞病毒)的发生率均未观察到差异。结论:我们建议RIST后的调理方案和免疫抑制策略应与GVHD的风险和因缺乏移植物抗白血病益处而引起的基础疾病复发的风险进行仔细平衡。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号